Hester Biosciences has informed about Statement Grievance Redressal Mechanism under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended on 30 September 2017.
The above information is a part of company’s filings submitted to BSE.